コンテンツへスキップ
Merck

Solar photocatalytic ozonation of a mixture of pharmaceutical compounds in water.

Chemosphere (2014-07-30)
Gracia Márquez, Eva M Rodríguez, Fernando J Beltrán, Pedro M Álvarez
要旨

Aqueous solutions of mixtures of four pharmaceutical compounds (atenolol, hydrochlorothiazide, ofloxacin and trimethoprim) both in Milli-Q ultrapure water and in a secondary effluent from a municipal wastewater treatment plant have been treated at pH 7 by different oxidation methods, such as conventional ozonation, photolytic ozonation, TiO2 catalytic ozonation, TiO2 photocatalytic oxidation and TiO2 photocatalytic ozonation. Experiments were carried out using a solar compound parabolic concentrator. The performance results have been compared in terms of removal of emerging contaminants (ECs), generation rate of phenolic intermediates, organic matter mineralization, ecotoxicity removal and enhancement of biodegradability. Also, the consumption of ozone to achieve certain treatment goals (95% removal of ECs and 40% mineralization) is discussed. Results reveal that solar photocatalytic ozonation is a promising oxidation method as it led to the best results in terms of EC mineralization (∼85%), toxicity removal (∼90%) and efficient use of ozone (∼2mgO3mgEC(-1) to achieve complete EC removal and ∼18mgO3mgTOC(-1) to achieve 40% EC mineralization, respectively).

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
酸化チタン(IV), nanopowder, 21 nm primary particle size (TEM), ≥99.5% trace metals basis
Sigma-Aldrich
酸化チタン(IV)、アナターゼ, nanopowder, <25 nm particle size, 99.7% trace metals basis
Sigma-Aldrich
トリメトプリム, ≥98.5%
Sigma-Aldrich
酸化チタン(IV), puriss., meets analytical specification of Ph. Eur., BP, USP, 99-100.5%
Sigma-Aldrich
酸化チタン(IV)、アナターゼ, powder, 99.8% trace metals basis
Sigma-Aldrich
酸化チタン(IV), ReagentPlus®, ≥99%
Sigma-Aldrich
酸化チタン(IV)、ルチル, powder, <5 μm, ≥99.9% trace metals basis
Sigma-Aldrich
酸化チタン(IV)、アナターゼ, powder, −325 mesh, ≥99% trace metals basis
Sigma-Aldrich
酸化チタン(IV)、ルチル, nanopowder, <100 nm particle size, 99.5% trace metals basis
Sigma-Aldrich
トリメトプリム, ≥99.0% (HPLC)
Sigma-Aldrich
酸化チタン(IV)、ルチル型/アナターゼ型混合物, nanopowder, <100 nm particle size (BET), 99.5% trace metals basis
Sigma-Aldrich
アテノロール, ≥98% (TLC), powder
Sigma-Aldrich
オフロキサシン, fluoroquinolone antibiotic
Sigma-Aldrich
チタン, foil, thickness 0.127 mm, 99.7% trace metals basis
Sigma-Aldrich
チタン, powder, <45 μm avg. part. size, 99.98% trace metals basis
Sigma-Aldrich
チタン, foil, thickness 0.25 mm, 99.7% trace metals basis
Sigma-Aldrich
酸化チタン(IV)、ルチル型/アナターゼ型混合物, nanoparticles, <150 nm particle size (volume distribution, DLS), dispersion, 40 wt. % in H2O, 99.5% trace metals basis
Sigma-Aldrich
チタン, powder, −100 mesh, 99.7% trace metals basis
USP
ヒドロクロロチアジド, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
酸化チタン(IV)、ルチル, ≥99.98% trace metals basis
Supelco
ヒドロクロロチアジド, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
酸化チタン(IV)、ルチル, 99.995% trace metals basis
Sigma-Aldrich
酸化チタン(IV), contains 1% Mn as dopant, nanopowder, <100 nm particle size (BET), ≥97%
USP
オフロキサシン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
チタン, wire, diam. 0.25 mm, 99.7% trace metals basis
Sigma-Aldrich
チタン, sponge, 1-20 mm, 99.5% trace metals basis
USP
トリメトプリム, United States Pharmacopeia (USP) Reference Standard
Supelco
トリメトプリム, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
酸化チタン(IV), nanowires, diam. × L ~100 nm × 10 μm
Sigma-Aldrich
チタン, foil, thickness 2.0 mm, 99.7% trace metals basis